All stock lists
SANUWAVE Health, Inc. (NASDAQ:SNWV)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
2.09-3.64 (-63.61%)
Market cap
$17.9M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 18, 2024
Website
Insider Score
––Not scored
SNWV Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From SNWV’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $43.9M
- Net income
- $14.3M
- Net margin
- 32.6%
Leverage17 / 20
Little or no net debt.
- Total debt
- $20.7M
- Cash
- $9.4M
- Net debt / EBITDA
- 0.58x
Liquidity10 / 20
Covers near-term obligations, without much room.
- Current assets
- $23.2M
- Current liabilities
- $18.2M
- Current ratio
- 1.28
Cash generation19 / 20
The business funds itself from operations.
- Operating cash flow
- $5.2M
- Free cash flow
- $6.2M
- FCF margin
- 14.1%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 8.6M
- Share growth (1y)
- 0.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
SNWV Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 9.74 M | 9.62 M | 13.09 M | 11.45 M | 10.16 M | 9.34 M |
| Revenue Growth (YoY) | -4.18 % | 2.97 % | 26.81 % | 22.34 % | 41.92 % | 61.46 % |
| Cost of Revenue | 2.31 M | 2.43 M | 3.39 M | 2.75 M | 2.21 M | 1.96 M |
| Gross Profit | 7.42 M | 7.18 M | 9.70 M | 8.70 M | 7.96 M | 7.38 M |
| SG&A Expense | 6.83 M | 7.65 M | 8.19 M | 6.89 M | 5.71 M | 6.00 M |
| R&D Expense | 628.00 K | 660.00 K | 606.00 K | 345.00 K | 194.00 K | 208.00 K |
| Operating Expenses | 7.70 M | 8.31 M | 9.09 M | 7.24 M | 6.08 M | 6.40 M |
| Operating Income | -280.00 K | -1.12 M | 615.00 K | 1.47 M | 1.88 M | 986.00 K |
| Pretax Income | -676.00 K | -1.44 M | 6.20 M | 10.32 M | 1.05 M | -5.68 M |
| Tax Provision | 6.00 K | 0.00 | 86.00 K | 0.00 | 0.00 | 0.00 |
| Net Income | -682.00 K | -1.44 M | 6.11 M | 10.32 M | 1.05 M | -5.68 M |
| EPS (Basic) | -0.08 | -0.17 | 0.71 | 1.21 | 0.01 | -0.66 |
| EPS (Diluted) | -0.08 | -0.17 | 0.02 | 1.13 | 0.01 | -0.66 |
| Shares Outstanding | 8.60 M | 8.59 M | 8.56 M | 8.57 M | 8.56 M | 8.55 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.